Ribozyme
Gene Therapy for Retinitis Pigmentosa
Summary
Retinitis
Pigmentosa is a genetic disorder affecting nearly 1.5
million people worldwide. Even
when treated, virtually all patients affected by this disease eventually
lose their vision.Ribozyme
Gene Therapy is an experimental method of treatment that offers new hope.
Web Page Created by Raymond Costantini
Best viewed at 800x600
pixels
University of Arizona x_ray@uswest.net
